Psychiatric implications of anti-seizure medications in epileptic population

被引:1
|
作者
Khalid, Bushra [1 ]
Waqar, Zaid [1 ]
Khan, Soban [1 ]
Ali, Ijaz [1 ]
Afzal, Naheed [1 ]
Irfan, Anum [1 ]
Malik, Waleed [1 ]
Adil, Malik Muhammad [1 ]
Saddiqa, Amina [1 ]
Khalil, Maryam [1 ]
Munawar, Zeeshan [1 ]
机构
[1] Pakistan Inst Med Sci, Islamabad, Pakistan
关键词
Epilepsy; Antiseizure medications; Psychiatric comorbidities; Valproate; MRI findings; DEPRESSION; CLASSIFICATION; COMORBIDITIES; DEFINITION; ILAE;
D O I
10.1186/s12883-024-03670-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and objective Epilepsy is a prevalent neurological disorder that affects a significant number of individuals globally. This condition is associated with a high occurrence of psychiatric comorbidities, which can significantly affect the quality of life of individuals affected. The aim of this study was to investigate the association between antiseizure therapies and the likelihood of psychiatric comorbidities in individuals with epilepsy.Methodology Data for this study was gathered from the Neurology referral center in Islamabad, Pakistan. A standardized questionnaire was utilized to gather data from 120 individuals diagnosed with epilepsy. The survey consisted of inquiries regarding the management of seizures, the utilization of anti-seizure medications, and the presence of psychiatric comorbidities. The data was analyzed using the Statistical Package for the Social Sciences (SPSS).Results The findings indicated that individuals who were using multiple antiseizure medications had a notably higher likelihood of having psychiatric comorbidities in comparison to those who were on mono therapy (p = 0.010). suggests that patients with unsuccessful seizure control are more probable to have psychiatric comorbidities as compared to those with good seizure control (p = 0.029).Conclusion To conclude poor seizure control and poly therapy are associated with increased risk of psychiatric comorbidities.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Anti-seizure medications for Lennox-Gastaut syndrome
    Brigo, Francesco
    Jones, Katherine
    Eltze, Christin
    Matricardi, Sara
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (04):
  • [22] Management of anti-seizure medications in lactating women with epilepsy
    Yan, Rong
    Tuo, Jinmei
    Tai, Zhenzhen
    Zhang, Haiqing
    Yang, Juan
    Yu, Changyin
    Xu, Zucai
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [23] Metabolic Effects of Anti-Seizure Medications: A Time to Reevaluate Risks?
    Asranna, Ajay
    Thomas, Sanjeev V.
    NEUROLOGY INDIA, 2021, 69 (04) : 964 - 965
  • [24] Which psychogenic non-epileptic seizures (PNES) patients are more likely to be treated with anti-seizure medications?
    Spierer, R.
    Herskovitz, M.
    EPILEPSIA, 2023, 64 : 516 - 516
  • [25] Epilepsy and Anti-Seizure Medications: Secret Agents for Endocrine Disruption
    Sazgar, Mona
    Mnatsakanyan, Lilit
    Pack, Alison M.
    Harden, Cynthia L.
    EPILEPSY CURRENTS, 2024, 24 (02) : 79 - 83
  • [26] The Effect of Anti-Seizure Medications on Lipid Values in Adults with Epilepsy
    Muller, Ashley
    Diaz-Arias, Luisa A.
    Cervenka, Mackenzie C.
    McDonald, Tanya J. W.
    ANNALS OF NEUROLOGY, 2023, 94 : S132 - S132
  • [27] The Effects Of Anti-Seizure Medications On Patients With Antibody Deficiency Syndrome
    Gavrilova, Tatyana
    Jyonouchi, Harumi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB253 - AB253
  • [28] The United States Pharmaceutical Supply Chain of Anti-Seizure Medications
    Meylor, J.
    Shahrukh, S.
    Javarayee, P.
    ANNALS OF NEUROLOGY, 2023, 94 : S62 - S62
  • [29] Interactions between anti-seizure medications and recommendations for combination treatment
    Hoppe, Barbara
    Weber, Yvonne
    Wolking, Stefan
    NERVENARZT, 2023, : 149 - 158
  • [30] Unravelling the Impact: Pulmonary Side Effects of Anti-Seizure Medications
    Butera, Ambra
    Pirrone, Martina
    Accetta, Arianna Santina
    Consoli, Carla
    Nicotera, Antonio Gennaro
    Turriziani, Laura
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2025, 21 (01) : 29 - 47